Oct 14, 2026 06:42AM
Aug 28, 2026 08:16AM
Jul 30, 2026 08:01AM
May 13, 2026 04:10PM
May 13, 2026 06:51AM
May 7, 2026 06:06AM
Mar 16, 2026 12:41PM H.C. Wainwright positive on Aprea (APRE) as APR-1051 shows 50% lesion reduction in endometrial cancer
Mar 16, 2026 09:00AM
Feb 18, 2026 08:02AM
Feb 12, 2026 08:30AM
Feb 4, 2026 08:32AM
Jan 29, 2026 08:29AM
Dec 19, 2025 04:13PM
Dec 18, 2025 08:33AM Aprea Therapeutics updates shareholders on clinical programs and 2026 outlook
Nov 12, 2025 04:28PM
Oct 24, 2025 08:31AM
Aug 12, 2025 08:29AM
May 14, 2025 04:37PM
Apr 17, 2025 07:01AM
Mar 25, 2025 04:22PM
Mar 11, 2025 08:32AM Aprea Therapeutics (APRE) Announces Agreement with MD Anderson Cancer Center to Explore APR-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma
Feb 5, 2025 08:01AM
Jan 16, 2025 06:53AM
Oct 23, 2024 08:31AM

479,048 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All